About 1 in 5 classified as overweight based on BMI alone considered to have obesity according to European society definition.

By Jarrett Renshaw (Reuters) -Within hours of taking office in January, President Donald Trump boasted about attracting $3 ...

The stocks listed here each increased their dividend payments by more than 10% recently. When you think of a great dividend ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

The upgrade from 'reduce' to 'buy' is based on a more optimistic view of the company's custom synthesis segment.

Eli Lilly and Johnson & Johnson, PPH’s largest holdings, are facing unique challenges, impacting the ETF’s overall ...

Buying $1000 In LLY: If an investor had bought $1000 of LLY stock 10 years ago, it would be worth $8,701.53 today based on a price of $771.99 for LLY at the time of writing.

Health news highlights the booming demand for obesity drugs in India with companies like Eli Lilly and Novo Nordisk vying for ...

While Eli Lilly has struggled in the past year due to competitive pressures, the statistical winds may finally favor LLY ...

Prime Medicine, Inc. achieved strong early data in CGD with PM359, surpassing efficacy thresholds. Click here to find out why ...

Do those on Zepbound have to switch to Wegovy after Caremark drops Zepbound from preferred coverage? What options are there?

Henry Liu, former director of the Federal Trade Commission’s Bureau of Competition under the Biden administration, has ...